首页> 美国卫生研究院文献>Tissue Engineering. Part C Methods >In Vitro and In Vivo Correlation of Bone Morphogenetic Protein-2 Release Profiles from Complex Delivery Vehicles
【2h】

In Vitro and In Vivo Correlation of Bone Morphogenetic Protein-2 Release Profiles from Complex Delivery Vehicles

机译:复杂交付工具的骨形态发生蛋白2释放曲线的体外和体内相关性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Local sustained delivery of bioactive molecules from biomaterials is a promising strategy to enhance bone regeneration. To optimize delivery vehicles for bone formation, the design characteristics are tailored with consequential effect on bone morphogenetic protein-2 (BMP-2) release and bone regeneration. Complying with the 3R principles (Replacement, Reduction, and Refinement), the growth factor release is often investigated in vitro using several buffers to mimic the in vivo physiological environment. However, this remains an unmet need. Therefore, this study investigates the in vitro-in vivo correlation (IVIVC) of BMP-2 release from complex delivery vehicles in several commonly used in vitro buffers: cell culture model, phosphate buffered saline, and a strong desorption buffer. The results from this study showed that the release environment affected the BMP-2 release profiles, creating distinct relationships between release versus time and differences in extent of release. According to the guidance set by the U.S. Food and Drug Administration (FDA), IVIVC resulted in level A internal predictability for individual composites. Since the IVIVC was influenced by the BMP-2 loading method and composite surface chemistry, the external predictive value of the IVIVCs was limited. These results show that the IVIVCs can be used for predicting the release of an individual composite. However, the models cannot be used for predicting in vivo release for different composite formulations since they lack external predictability. Potential confounding effects of drug type, delivery vehicle formulations, and application site should be added to the equation to develop one single IVIVC applicable for complex delivery vehicles. Altogether, these results imply that more sophisticated in vitro systems should be used in bone regeneration to accurately discriminate and predict in vivo BMP-2 release from different complex delivery vehicles.
机译:从生物材料局部持续递送生物活性分子是增强骨再生的有前途的策略。为了优化用于骨形成的运载工具,对设计特征进行了定制,从而对骨形态发生蛋白2(BMP-2)的释放和骨再生产生了影响。遵循3R原理(置换,还原和精制),经常在体外使用几种缓冲液模拟体内生理环境来研究生长因子的释放。但是,这仍然是未满足的需求。因此,本研究调查了在几种常用的体外缓冲液中,复杂的运载工具释放BMP-2的体外-体内相关性(IVIVC):细胞培养模型,磷酸盐缓冲盐水和强解吸缓冲液。这项研究的结果表明,释放环境影响了BMP-2的释放曲线,在释放与时间和释放程度差异之间建立了独特的关系。根据美国食品药品监督管理局(FDA)制定的指南,IVIVC对单个复合材料的内部可预测性为A级。由于IVIVC受BMP-2加载方法和复合表面化学的影响,因此IVIVC的外部预测价值受到限制。这些结果表明,IVIVC可用于预测单个复合物的释放。但是,这些模型不能用于预测不同复合制剂的体内释放,因为它们缺乏外部可预测性。药物类型,输送媒介物配方和应用场所的潜在混杂效应应添加到方程中,以开发一种适用于复杂输送媒介物的单一IVIVC。总而言之,这些结果意味着在骨骼再生中应使用更复杂的体外系统,以准确地区分和预测体内BMP-2从不同复杂递送载体中的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号